Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr 24;14(5):513.
doi: 10.3390/biom14050513.

The Exploitation of the Glycosylation Pattern in Asthma: How We Alter Ancestral Pathways to Develop New Treatments

Angelika Muchowicz  1 , Agnieszka Bartoszewicz  1 , Zbigniew Zaslona  1
Affiliations
Review

The Exploitation of the Glycosylation Pattern in Asthma: How We Alter Ancestral Pathways to Develop New Treatments

Angelika Muchowicz et al. Biomolecules. .

Abstract

Asthma has reached epidemic levels, yet progress in developing specific therapies is slow. One of the main reasons for this is the fact that asthma is an umbrella term for various distinct subsets. Due to its high heterogeneity, it is difficult to establish biomarkers for each subset of asthma and to propose endotype-specific treatments. This review focuses on protein glycosylation as a process activated in asthma and ways to utilize it to develop novel biomarkers and treatments. We discuss known and relevant glycoproteins whose functions control disease development. The key role of glycoproteins in processes integral to asthma, such as inflammation, tissue remodeling, and repair, justifies our interest and research in the field of glycobiology. Altering the glycosylation states of proteins contributing to asthma can change the pathological processes that we previously failed to inhibit. Special emphasis is placed on chitotriosidase 1 (CHIT1), an enzyme capable of modifying LacNAc- and LacdiNAc-containing glycans. The expression and activity of CHIT1 are induced in human diseased lungs, and its pathological role has been demonstrated by both genetic and pharmacological approaches. We propose that studying the glycosylation pattern and enzymes involved in glycosylation in asthma can help in patient stratification and in developing personalized treatment.

Keywords: asthma; biomarkers; chitotriosidase 1; glycobiology; glycosylation.

PubMed Disclaimer

Conflict of interest statement

The authors were employed by the company Molecure S.A.

Figures

Figure 1
Figure 1
Changes in protein glycosylation shape the immune cells’ function and trafficking in asthma. The activation of Th-2 lymphocytes by dendritic cells (DC) leads to cytokine production and Th-2 cell expansion. IL-13 prompts the overgrowth of smooth muscle cells (SMCs), modifies functions of alveolar macrophages (MAs), and leads to the fucosylation of epithelial surface proteins. Due to the immune response, the hyperproduction of mucus occurs and affects the MUC5AC/MUC5B ratio. At the same time, IL-4 supports B cells in antibody production, which are also modified by glycans. Chemokine production increases the influx of myeloid cells, including monocytes (MOs) and neutrophils (NEUs). Modification by glycosylation receptors affects the cell’s trafficking (CD44 and Mac-1), function (TCR and CD25), and metabolism (Glut1).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Habib N., Pasha M.A., Tang D.D. Current Understanding of Asthma Pathogenesis and Biomarkers. Cells. 2022;11:2764. doi: 10.3390/cells11172764. - DOI - PMC - PubMed
    1. Hammad H., Lambrecht B.N. The Basic Immunology of Asthma. Cell. 2021;184:1469–1485. doi: 10.1016/j.cell.2021.02.016. - DOI - PubMed
    1. Fahy J.V. Type 2 inflammation in asthma–present in most, absent in many. Nat. Rev. Immunol. 2015;15:57–65. doi: 10.1038/nri3786. - DOI - PMC - PubMed
    1. Klein Wolterink R.G., Kleinjan A., van Nimwegen M., Bergen I., de Bruijn M., Levani Y. Hendriks RW Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 2012;42:1106–1116. doi: 10.1002/eji.201142018. - DOI - PubMed
    1. Ilmarinen P., Tuomisto L.E., Kankaanranta H. Phenotypes, Risk Factors, and Mechanisms of Adult-Onset Asthma. Mediat. Inflamm. 2015;2015:514868. doi: 10.1155/2015/514868. - DOI - PMC - PubMed